GlassScriptPhysician profile
Mehdi Rambod
NPI 1619262755
$9,557.99
in general payments reported to CMS, 2019-2025
27 companies · $154 in 2025
The $154 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,059 · 2020: $604 · 2021: $249 · 2022: $979 · 2023: $1,240 · 2024: $3,274 · 2025: $154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,552 · Travel and Lodging: $2,116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,551.90 |
| Travel and Lodging | $2,115.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,272.66 | 2019-2023 | Optis |
| Philips North America LLC | $1,586.19 | 2022-2024 | (Bh4) Igt Devices Undivided, (9520) Igt Devices Undivided |
| Edwards Lifesciences Corporation | $1,414.06 | 2023-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Penumbra, INC. | $582.46 | 2022-2023 | Indigo System |
| Abiomed | $532.87 | 2020-2023 | Impella |
| Inari Medical, INC. | $452.15 | 2020-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Cardiva Medical, INC. | $397.74 | 2019-2024 | Optowire |
| Boston Scientific Corporation | $370.30 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $311.99 | 2019-2024 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $244.31 | 2019 | |
| Medtronic, INC. | $210.19 | 2023 | Corevalve Evolut R |
| Impulse Dynamics (USA) INC. | $184.80 | 2022 | |
| Janssen Pharmaceuticals, INC | $173.25 | 2021-2022 | |
| Cook Medical LLC | $172.41 | 2019 | |
| Chiesi USA, INC. | $163.11 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $153.68 | 2025 | |
| Ekos Corporation | $97.63 | 2019 | |
| Acist Medical Systems, INC. | $67.90 | 2022-2024 | |
| Actelion Pharmaceuticals US, INC. | $29.94 | 2021 | |
| Tactile Systems Technology INC | $27.25 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $26.67 | 2021-2022 | |
| Amgen INC. | $15.21 | 2020 | |
| Bard Peripheral Vascular, INC. | $15.16 | 2023 | Denali Vena Cava Filter |
| E.R. Squibb & Sons, L.L.C. | $15.00 | 2020 | |
| La Jolla Pharmaceutical Company | $14.60 | 2019 | |
| Merck Sharp & Dohme LLC | $14.17 | 2022 | |
| Arbor Pharmaceuticals, INC. | $12.29 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mehdi Rambod listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.